Skip to main content
Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.980
-0.160 (-5.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.995
+0.015 (0.50%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Evotec SE Revenue

In the year 2025, Evotec SE had annual revenue of 788.37M EUR, down -1.08%. Evotec SE had revenue of 253.27M in the quarter ending December 31, 2025, with 14.49% growth.

Revenue (ttm)
788.37M EUR
Revenue Growth
-1.08%
P/S Ratio
1.16
Revenue / Employee
176,488 EUR
Employees
4,467
Market Cap
1.07B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025788.37M-8.59M-1.08%
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
ANI Pharmaceuticals 883.37M
Tilray Brands 858.28M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Alvotech 588.90M
Harrow 272.30M
Revenue Rankings

EVO News

More News